Netherlands-based medical device maker GTX medical has merged with US-based medical device developer NeuroRecovery Technologies (NRT) to create a leading global company committed to developing novel neuromodulation therapies to improve functional recovery of people with Spinal Cord Injuries (SCI). The merged entity will be known as GTX medical BV.
The merged company is developing Targeted Epidural Spine Stimulation (TESS), an implantable spinal cord stimulation system with real-time motion feedback. This system is in late-stage development and has already been shown to restore locomotion in a select number of patients with spinal cord injury. A second, non-invasive product offering – Transcutaneous Spinal Cord Stimulation (tSCS) – is being developed to restore upper limb movement and hand function.
Congratulations to our portfolio entrepreneurs of GTX!